논문성과
							
			
				
				논문성과
			
												 
				
				
					
								- 
		    		
    			
    				39    				    			
    		 Higher Genetic Risk Loads Confer More Diverse Manifestations and Higher Risk of Lupus Nephritis in Systemic Lupus Erythematosus				
				AUTHOR : Kwon YC, Ha E, Kwon HH, Park DJ, Shin JM, Joo YB, Chung WT, Yoo DH, Lee HS, Kim K, Bae SC, Bang SY.
 JOURNAL : Arthritis & rheumatology
 YEAR : 2023
 VOL : Sep;75(9)
 PAGE : 1566-1572
- 
		    		
    			
    				38    				    			
    		 Risk of venous thromboembolism in Korean patients with rheumatoid arthritis treated with Janus kinase inhibitors: A nationwide population-based study				
				AUTHOR : Song YJ, Cho SK, Kim JY, You SH, Kim H, Jung SY, Sung YK.
 JOURNAL : Seminars in arthritis and rheumatism
 YEAR : 2023
 VOL : Aug:61
 PAGE : 152214.
- 
		    		
    			
    				37    				    			
    		 Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes. 				
				AUTHOR : Choi MY, Chen I, Clarke AE, Fritzler MJ, Buhler KA, Urowitz M, Hanly J, St-Pierre Y, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Ramsey-Goldman R, Manzi S, Jönsen A, Alarcón GS, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Lim S, Inanc M, Kalunian K, Jacobsen S, Peschken C, Kamen DL, Askanase A, Buyon JP, Sontag D, Costenbader KH.
 JOURNAL : Annals of the rheumatic diseases
 YEAR : 2023
 VOL : Jul;82(7)
 PAGE : 927-936
- 
		    		
    			
    				36    				    			
    		 Pregnancy Outcomes Associated With Biologic Agent Exposure in Patients With Several Rheumatic Diseases and Inflammatory Bowel Diseases				
				AUTHOR : Ahn SM, Joo YB, Kim YJ, Bang SY, Lee HS.
 JOURNAL : Journal of Korean medical science
 YEAR : 2023
 VOL : Jun 5;38(22)
 PAGE : e172
- 
		    		
    			
    				35    				    			
    		 Angiotentin receptor blockers, but not angiotensin-converting enzyme inhibitors, inhibit abnormal bone changes in spondyloarthritis 				
				AUTHOR : Choi JS, Kim JY, Ahn MJ, Jang H, Song S, Jo S, Choi SH, Park YS, Kim TH, Shim SC
 JOURNAL : Experimental & Molecule Medicine
 YEAR : 2023
 VOL :
 PAGE :
- 
		    		
    			
    				34    				    			
    		 Eosinophil-derived TGFβ1 controls the new bone formation in chronic rhinosinusitis with nasal polyps				
				AUTHOR : Jo S, Lee SH, Jo HR, Weon S, Jeon C, Park MK, Kim TH, Cho SH.
 JOURNAL : Rhinology
 YEAR : 2023
 VOL : Aug 1;61(4)
 PAGE : 338-347
- 
		    		
    			
    				33    				    			
    		 Elevated BMPR2 expression amplifies osteoblast differentiation in ankylosing spondylitis				
				AUTHOR : Jo S, Lee SH, Jeon C, Jo HR, Ko E, Whangbo M, Kim TJ, Park YS, Kim TH.
 JOURNAL : Journal of rheumatic diseases
 YEAR : 2023
 VOL : Oct 1;30(4)
 PAGE : 243-250
- 
		    		
    			
    				32    				    			
    		 CCL20 inhibition for treating inflammation in ankylosing spondylitis				
				AUTHOR : Won EJ, Kim HJ, Lee YJ, Kim MJ, Lee HI, Jang HH, Kim SH, Kang JH, Park KJ, Shim SC, Jo S, Kim TH, Kim TJ.
 JOURNAL : Rheumatology
 YEAR : 2023
 VOL : Jun 5
 PAGE : kead268.
- 
		    		
    			
    				31    				    			
    		 Abnormal kynurenine level contributes to the pathological bone features of ankylosing sopondylitis				
				AUTHOR : Jeon C, Jang Y, Lee SH, Weon S, Park H, Lee S, Oh Y, Choi SH, Wang SE, Kim TH, Sung IH, Jo S.
 JOURNAL : International immunopharmacology
 YEAR : 2023
 VOL : May:118
 PAGE : 110132
- 
		    		
    			
    				30    				    			
    		 Clinical and genetic factors associated with radiographic damage in patients with ankylosing spondylitis				
				AUTHOR : Nam B, Jo S, Bang SY, Park Y, Shin JH, Park YS, Lee S, Joo KB, Kim TH.
 JOURNAL : Annals of the rheumatic diseases
 YEAR : 2023
 VOL : Apr;82(4)
 PAGE : 527-532